Sailesh Raj Bhan
CIO – Equity Investments at Nippon India
Sailesh Raj Bhan is named on 3 schemes at Nippon India. Of the 3 ranked with a three-year record, 3-year CAGR runs from 17.8% (Nippon India Pharma Fund - Direct Plan - Growth Option) down to 9.7% (Nippon India Large Cap Fund - Direct Plan - Growth Option), across Sectoral/ Thematic, Multi Cap Fund, Large Cap Fund. Returns are computed from AMFI NAV history and are net of expenses; the roles and dates come from Nippon India's SEBI filings.
Background
- Qualifications
- MBA(Finance) CFA (ICFAI)
- Experience
- Over 29 years experience in Equity Securities research and analysis February 2014 to till date Deputy CIO - Equity Investments, NAM India, – managing various Schemes of NIMF. May 2010 to January 2014 Sr. Fund Manager - Investment Equity Oct 2006 to April 2009 Fund Manager -Equity Nov 2003 – Sept 2006 NAM India - Senior Analyst 2001-2003 Emkay Share & Stock Broker Pvt. Ltd Head – Research 1996-2001 Shah & Sequeira Invst. Pvt. Ltd Analyst - Equity research 1995-1996 ICFAI- Securities Research Center Analyst - Equity Research
Funds Sailesh Raj Bhan manages
3Ranked by 3Y CAGR. Schemes without a three-year record yet are not listed. Open a fund for NAV history, rolling returns, risk metrics and peer rank.
| 1 | Nippon India Pharma Fund | ★★★★☆ | +10.7% | +17.8% | +12.9% | 1.00% | ₹8,513Cr |
| 2 | Nippon India Multi Cap Fund | ★★☆☆☆ | -4.0% | +12.0% | +14.9% | 0.88% | ₹52,649Cr |
| 3 | Nippon India Large Cap Fund | ★★★★★ | -7.2% | +9.7% | +11.5% | 0.88% | ₹51,621Cr |
NAV data as of 05 Oct 2026. Role, qualifications and tenure are disclosures from Nippon India’s Scheme Information Documents and Statement of Additional Information — SEBI filings, not our assessment of anyone. Returns are computed from AMFI NAV history; see our methodology. A fund’s performance is not attributable to one person, and nothing here is investment advice.